Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Questions and... Speculations

<< Previous

Bullboard Posts

Next >>

Comment by steadfaston Jun 17, 2021 9:28am

149 Views

Post# 33401129

RE:Questions and... Speculations

MoneyMouth - you are 100% correct. SVA must abide under strict confidentiality
agreements with Big Pharma colloborations. If the names of the Pharmas were ever
carelessly mentioned on a BB, the Big Pharmas would never trust SVA again, SVA
would be toast. As shareholders we are not privy to this information and must respect
the confidentiality.

We do know we have the only Clinical Patient in the World who is 14 months+
insulin independent. SVA are way ahead of the competition. We have a pouch that
does not fibrose. The size of SEMMA device will cause it to fibrose. Via-Cyte have
experienced fibrose.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing